Production (Stage)
CorMedix Inc.
CRMD
$12.36
$0.100.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 25.22% | 172.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 25.22% | 172.43% | |||
| Cost of Revenue | 35.82% | 71.22% | |||
| Gross Profit | 24.81% | 178.88% | |||
| SG&A Expenses | -7.84% | 15.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.73% | 23.95% | |||
| Operating Income | 55.58% | 493.51% | |||
| Income Before Tax | 53.32% | 584.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 53.32% | 584.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 53.32% | 584.89% | |||
| EBIT | 55.58% | 493.51% | |||
| EBITDA | 55.22% | 507.17% | |||
| EPS Basic | 44.54% | 563.77% | |||
| Normalized Basic EPS | 44.59% | 563.73% | |||
| EPS Diluted | 37.05% | 563.77% | |||
| Normalized Diluted EPS | 36.77% | 563.73% | |||
| Average Basic Shares Outstanding | 6.07% | 4.56% | |||
| Average Diluted Shares Outstanding | 12.14% | 4.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||